CMV-Reactivation after allogeneic Bone Marrow Transplantation Approval of the Drug Letermovir recommended in the EU

被引：0
|
作者：
不详
机构：
来源：
TRANSFUSION MEDICINE AND HEMOTHERAPY | 2017年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：430 / 430
页数：1
相关论文
共 50 条
  • [11] Multipotent Vδ2-negative γδT-cells after CMV-reactivation in allogeneic stem cell transplantation
    Kuball, Jurgen
    Scheper, Wouter
    van Dorp, Suzanne
    Kersting, Sabina
    Pietersma, Floor
    Hol, Samantha
    Marcu-Malina, Victoria
    Becke, Sabine
    Plachter, Bodo
    van Baarle, Debbie
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [12] Effect of the donor CMV status on CMV reactivation after allogeneic transplantation
    Nürnberger, W
    Krempe, C
    Steinhagen, G
    Adams, O
    Göbel, U
    BONE MARROW TRANSPLANTATION, 1999, 23 : S66 - S66
  • [13] Induction of Multipotent Vδ2-negative γδT-cells After CMV-reactivation in Allogeneic Stem Cell Transplantation
    Scheper, Wouter
    van Dorp, Suzanne
    Kersting, Sabina
    Pietersma, Floor
    Hol, Samantha
    Sebestyen, Zsolt
    Heijhuurs, Sabine
    Macu-Malina, Victoria
    Grunder, Cordula
    Becke, Sabine
    Plachter, Bodo
    van Baarle, Debbie
    Kuball, Jurgen
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 773 - 773
  • [14] Low incidence of CMV reactivation and infection after allogeneic bone marrow transplantation (BMT) incorporating post-transplantation cyclophosphamide (Cy).
    Symons, Heather J.
    Luznik, Leo
    Phelps, Michele
    Crawford, Angelita
    McIntyre, Katherine
    Levy, M. Yair
    Jones, Richard J.
    Fuchs, Ephraim J.
    BLOOD, 2006, 108 (11) : 809A - 810A
  • [15] The role of Vd1 positive gdT-cells in controlling CMV-reactivation after allogeneic stem cell transplantation
    van Dorp, S.
    Pietersma, F.
    Heijhuurs, S.
    Marcu-Malina, V
    Minnema, M.
    Becke, S.
    Plachter, B.
    van Baarle, d
    Kuball, J.
    ONKOLOGIE, 2010, 33 : 264 - 265
  • [16] CMV REACTIVATION AND ITS IMPACT ON SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN LETERMOVIR ERA - A SINGLE CENTRE STUDY
    Desnica, Lana
    Durakovic, Nadira
    Peric, Zinaida
    Bosnjak, Zrinka
    Seiwerth, Ranka Serventi
    Sertic, Dubravka
    Vulic, Ante
    Mikulic, Mirta
    Vranjes, Violeta Rezo
    Roncevic, Pavle
    Pulanic, Drazen
    Rustan, Nurka
    Grubic, Zorana
    Vrhovac, Radovan
    BONE MARROW TRANSPLANTATION, 2024, 59 : 434 - 434
  • [17] Reduction of HBV virological reactivation after allogeneic bone marrow transplantation by famciclovir
    Lau, GKK
    Liang, R
    Lie, A
    Yuen, ST
    Lee, CK
    Lim, WL
    HEPATOLOGY, 1998, 28 (04) : 590A - 590A
  • [18] Additional Evidence for the Efficacy of Letermovir in the Prophylaxis of CMV Reactivation and Disease in Adults after allogeneic HSCT
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2022, 49 (04) : 269 - 269
  • [19] CMV REACTIVATION AFTER STOPPING LETERMOVIR PRIMARY PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 93 - 93
  • [20] Multipotent Vdelta2-negative gamma-delta-T-cells after CMV-reactivation in allogeneic stem cell transplantation
    Scheper, W.
    van Dorp, S.
    Kersting, S.
    Pietersma, F.
    Hol, S.
    Marcu-Malina, V.
    Becke, S.
    Plachter, B.
    van Baarle, D.
    Kuball, J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S325 - S325
12345